General Information of Drug Off-Target (DOT) (ID: OTA4B1SG)

DOT Name Transcription factor AP-2-epsilon (TFAP2E)
Synonyms AP2-epsilon; Activating enhancer-binding protein 2-epsilon
Gene Name TFAP2E
Related Disease
Neoplasm ( )
Adenoma ( )
Advanced cancer ( )
Colorectal carcinoma ( )
Neuroblastoma ( )
Skin neoplasm ( )
Gonorrhea ( )
Gastric cancer ( )
Stomach cancer ( )
UniProt ID
AP2E_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF03299
Sequence
MLVHTYSAMERPDGLGAAAGGARLSSLPQAAYGPAPPLCHTPAATAAAEFQPPYFPPPYP
QPPLPYGQAPDAAAAFPHLAGDPYGGLAPLAQPQPPQAAWAAPRAAARAHEEPPGLLAPP
ARALGLDPRRDYATAVPRLLHGLADGAHGLADAPLGLPGLAAAPGLEDLQAMDEPGMSLL
DQSVIKKVPIPSKASSLSALSLAKDSLVGGITNPGEVFCSVPGRLSLLSSTSKYKVTVGE
VQRRLSPPECLNASLLGGVLRRAKSKNGGRCLRERLEKIGLNLPAGRRKAANVTLLTSLV
EGEAVHLARDFGYVCETEFPAKAAAEYLCRQHADPGELHSRKSMLLAAKQICKEFADLMA
QDRSPLGNSRPALILEPGVQSCLTHFSLITHGFGGPAICAALTAFQNYLLESLKGLDKMF
LSSVGSGHGETKASEKDAKHRK
Function
Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-epsilon may play a role in the development of the CNS and in cartilage differentiation.
Tissue Specificity Expressed in skin, primary keratinocytes, immortalized keratinocytes, and HeLa cell line.
Reactome Pathway
Activation of the TFAP2 (AP-2) family of transcription factors (R-HSA-8866907 )
Negative regulation of activity of TFAP2 (AP-2) family transcription factors (R-HSA-8866904 )

Molecular Interaction Atlas (MIA) of This DOT

9 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Neoplasm DISZKGEW Definitive Biomarker [1]
Adenoma DIS78ZEV Strong Genetic Variation [2]
Advanced cancer DISAT1Z9 Strong Altered Expression [3]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [4]
Neuroblastoma DISVZBI4 Strong Biomarker [1]
Skin neoplasm DIS16DDV Strong Altered Expression [1]
Gonorrhea DISQ5AO6 Disputed Genetic Variation [3]
Gastric cancer DISXGOUK Limited Biomarker [5]
Stomach cancer DISKIJSX Limited Biomarker [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
4 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Transcription factor AP-2-epsilon (TFAP2E). [6]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Transcription factor AP-2-epsilon (TFAP2E). [7]
Urethane DM7NSI0 Phase 4 Urethane decreases the expression of Transcription factor AP-2-epsilon (TFAP2E). [8]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Transcription factor AP-2-epsilon (TFAP2E). [10]
------------------------------------------------------------------------------------
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Transcription factor AP-2-epsilon (TFAP2E). [9]
------------------------------------------------------------------------------------

References

1 Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells.Oncol Rep. 2017 Apr;37(4):2459-2464. doi: 10.3892/or.2017.5477. Epub 2017 Feb 24.
2 Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas.Endocr Relat Cancer. 2012 Nov 19;19(6):805-16. doi: 10.1530/ERC-12-0251. Print 2012 Dec.
3 Efficacy of decitabine-loaded gelatinases-stimuli nanoparticles in overcoming cancer drug resistance is mediated via its enhanced demethylating activity to transcription factor AP-2 epsilon.Oncotarget. 2017 Sep 26;8(70):114495-114505. doi: 10.18632/oncotarget.21274. eCollection 2017 Dec 29.
4 TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer.Oncology. 2015;88(2):122-32. doi: 10.1159/000362820. Epub 2014 Oct 23.
5 TFAP2E methylation promotes 5fluorouracil resistance via exosomal miR?06a?p and miR?21 in gastric cancer MGC?03 cells.Mol Med Rep. 2019 Jul;20(1):323-331. doi: 10.3892/mmr.2019.10237. Epub 2019 May 14.
6 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
7 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
8 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Comparison of transcriptome expression alterations by chronic exposure to low-dose bisphenol A in different subtypes of breast cancer cells. Toxicol Appl Pharmacol. 2019 Dec 15;385:114814. doi: 10.1016/j.taap.2019.114814. Epub 2019 Nov 9.